Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer
Yuji Ikeda(Kansai Medical University), Shiro Kōzuma(University of Tokyo Hospital)
Cited by 15
Related Papers
Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer
|Journal of Immunotherapy|2018|30